Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05645523
EARLY_PHASE1

Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Sponsor: St. Jude Children's Research Hospital

View on ClinicalTrials.gov

Summary

The purpose of the study is to find out the usefulness and safety of a dye called Indocyanine Green (ICG for short). This dye will be used to help the surgeon find lymph nodes draining solid tumors inside the abdomen that need to be removed. This may also help the surgeon to find if the cancer has moved to other lymph nodes outside of the known area. Primary Objectives * To determine the percentage of patients in whom Indocyanine Green (ICG)-guided sentinel lymph node (SLN) mapping was successful at the time of retroperitoneal lymph node dissection for staging of visceral solid tumors. * To determine the percentage of patients with grade 3 or higher adverse events related to ICG use.

Official title: Feasibility and Safety of Indocyanine Green (ICG) Guided Sentinel Lymph Node Mapping for Pediatric Visceral Solid Tumors

Key Details

Gender

All

Age Range

Any - 20 Years

Study Type

INTERVENTIONAL

Enrollment

25

Start Date

2023-10-24

Completion Date

2026-12

Last Updated

2026-02-25

Healthy Volunteers

No

Conditions

Interventions

DRUG

Indocyanine Green

Given in to the vein (IV)

Locations (3)

Lurie Children's Hospital

Chicago, Illinois, United States

Children's Hospital of Pittsburgh of UPMC

Pittsburgh, Pennsylvania, United States

St. Jude Children's Research Hospital

Memphis, Tennessee, United States